Pure Global

IntelliPlex HCV Genotyping Kit - Taiwan Registration 6e3ebc8c7c00c30943e3dc76c4c9f844

Access comprehensive regulatory information for IntelliPlex HCV Genotyping Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 6e3ebc8c7c00c30943e3dc76c4c9f844 and manufactured by PLEXBIO CO., LTD.. The authorized representative in Taiwan is PLEXBIO CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
6e3ebc8c7c00c30943e3dc76c4c9f844
Registration Details
Taiwan FDA Registration: 6e3ebc8c7c00c30943e3dc76c4c9f844
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IntelliPlex HCV Genotyping Kit
TW: ๅš้ŒธCๅž‹่‚็‚Ž็—…ๆฏ’ๅŸบๅ› ๅˆ†ๅž‹ๆชขๆธฌ่ฉฆๅŠ‘ๅฅ—็ต„
Risk Class 2
MD

Registration Details

6e3ebc8c7c00c30943e3dc76c4c9f844

Ministry of Health Medical Device Manufacturing No. 006709

Company Information

Taiwan, Province of China

Product Details

This product is a qualitative in vitro diagnostic molecular detection reagent, used to distinguish 6 major genotypes (1 to 6) and 2 subtypes (1a and 1b) of hepatitis C virus (HCV) in samples from serum or plasma, and needs to be used with "Borhen" microdish cleaning machine and "Borhenium" fluorescence analyzer. This product is not intended for donation screening of blood, serum, plasma, or tissue samples, or diagnostic tests to confirm HCV infection.

B Hematology and pathology devices

B4020 Analyze specific reagents

Produced in Taiwan, China

Dates and Status

May 14, 2020

May 14, 2025